Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNB-101 in Extensive Stage Small Cell Lung Cancer
NCT07391813Phase 2Recruiting
- Sponsor
- SN BioScience
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of SNB-101 in small cell lung cancer (SCLC), sponsored by SN BioScience. Started Mar 2026; status: recruiting.
02
Drugs
SNB-101
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT07391813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391813.